CBS 2019
CBSMD教育中心
中 文

Scientific Library

Abstract

Recommended Article

AIM2-driven inflammasome activation in heart failure Mortality Following Cardiovascular and Bleeding Events Occurring Beyond 1 Year After Coronary Stenting - A Secondary Analysis of the Dual Antiplatelet Therapy (DAPT) Study The Evolution of β-Blockers in Coronary Artery Disease and Heart Failure (Part 1/5) Inhibition of Platelet Aggregation After Coronary Stenting in Patients Receiving Oral Anticoagulation Clinical epidemiology of heart failure with preserved ejection fraction (HFpEF) in comparatively young hospitalized patients Effect of Luseogliflozin on Heart Failure With Preserved Ejection Fraction in Patients With Diabetes Mellitus The prevalence and importance of frailty in heart failure with reduced ejection fraction - an analysis of PARADIGM-HF and ATMOSPHERE A Randomized Controlled Trial to Evaluate the Safety and Efficacy of Cardiac Contractility Modulation

Original Research2021 Jun 12;cvab202.

JOURNAL:Cardiovasc Res. Article Link

AIM2-driven inflammasome activation in heart failure

Z Onódi, M Ruppert, D Kucsera et al. Keywords: canakinumab; cardiomyopathy; drug repurposing; heart failure; inflammation; probenecid

Full Text PDF